Page last updated: 2024-10-29

iofetamine and Alzheimer Disease

iofetamine has been researched along with Alzheimer Disease in 52 studies

Iofetamine: An amphetamine analog that is rapidly taken up by the lungs and from there redistributed primarily to the brain and liver. It is used in brain radionuclide scanning with I-123.

Alzheimer Disease: A degenerative disease of the BRAIN characterized by the insidious onset of DEMENTIA. Impairment of MEMORY, judgment, attention span, and problem solving skills are followed by severe APRAXIAS and a global loss of cognitive abilities. The condition primarily occurs after age 60, and is marked pathologically by severe cortical atrophy and the triad of SENILE PLAQUES; NEUROFIBRILLARY TANGLES; and NEUROPIL THREADS. (From Adams et al., Principles of Neurology, 6th ed, pp1049-57)

Research Excerpts

ExcerptRelevanceReference
" Treatment with memantine prevented the chorea movement and the progression of Huntington's disease."8.31Memantine administration prevented chorea movement in Huntington's disease: a case report. ( Hirano, M; Ikegawa, A; Kusunoki, S; Mitsui, Y; Nagai, Y; Oda, I; Saigoh, K; Samukawa, M; Yamagishi, Y; Yoshikawa, K, 2023)
" Treatment with memantine prevented the chorea movement and the progression of Huntington's disease."4.31Memantine administration prevented chorea movement in Huntington's disease: a case report. ( Hirano, M; Ikegawa, A; Kusunoki, S; Mitsui, Y; Nagai, Y; Oda, I; Saigoh, K; Samukawa, M; Yamagishi, Y; Yoshikawa, K, 2023)
"Perfusion in the patients with Alzheimer's disease was decreased compared with that of the subjects."2.67SPECT brain imaging in Alzheimer's disease during treatment with oral tetrahydroaminoacridine and lecithin. ( Cohen, MB; Fitten, LJ; Graham, LS; Lake, RR; Perryman, KM; Sevrin, R, 1992)
"Patients with Alzheimer's disease (AD) experience a wide array of cognitive deficits, which typically include the impairment of explicit memory."1.43Improvement of memory recall by quercetin in rodent contextual fear conditioning and human early-stage Alzheimer's disease patients. ( Akanabe, H; Chikaishi, T; Hayakawa, M; Hayashi, Y; Inuzuka, T; Islam, S; Itoh, M; Itoh, Y; Kobori, M; Li, S; Mori, T; Muro, T; Nakabayashi, R; Nakagawa, K; Nakagawa, T; Nishida, E; Ohta, K; Ohzawa, K; Saito, K; Suzuki, C; Ueda, M; Wang, MX; Yamada, Y; Yanagida, D, 2016)
"Twenty-three patients with probable Alzheimer's disease, 22 patients with mild cognitive impairment who eventually developed Alzheimer's disease, eight patients with mild cognitive impairment who did not develop dementia, and 19 cognitively normal subjects were included in the study."1.31Combined Analysis of CSF Tau Levels and [(123)I]Iodoamphetamine SPECT in Mild Cognitive Impairment: Implications for a Novel Predictor of Alzheimer's Disease. ( Arai, H; Chiba, H; Higuchi, M; Hirai, H; Itoh, M; Maruyama, M; Matsui, T; Okamura, N; Sasaki, H; Seki, T; Tanji, H, 2002)
"In patients with Alzheimer's disease, the CBF (ratio to cerebellum) decreased significantly in the frontal cortex and the parietal cortex compared with the control values."1.29[Benzodiazepine receptor and cerebral blood flow in early Alzheimer's disease--SPECT study using 123I-iomazenil and 123I-IMP]. ( Kitamura, S; Komaba, Y; Komiyama, T; Koshi, Y; Mishina, M; Ohyama, M; Sakayori, O; Terashi, A; Tsuganesawa, T, 1996)
"123I-IMP-SPECT in a patient with presenile dementia with motor neuron disease differed significantly from uptake in a case with Alzheimer's disease."1.28[123I-IMP-SPECT finding of a case of presenile dementia with motor neuron disease--comparison between Alzheimer's disease, Pick's disease and presenile dementia with motor neuron disease]. ( Mitsuyama, Y, 1989)
"Eighteen patients with Alzheimer's disease (AD), 5 patients with Pick disease (PD), 6 patients with other types of degenerative dementia (O) and 12 age-matched normal control subjects (N) were studied using N-isopropyl p-[I-123]iodoamphetamine (I-123 IMP) with SPECT."1.28[N-isopropyl I-123 p-iodoamphetamine (IMP) brain SPECT in Alzheimer's disease]. ( Iio, M; Kosaka, N; Momose, T; Nishikawa, J; Ohtake, T; Watanabe, T; Yoshikawa, K, 1989)
"Iofetamine I 123 uptake was measured in right and left frontal, temporal, parietal, and occipital cortices."1.27Single photon emission computed tomography in Alzheimer's disease. Abnormal iofetamine I 123 uptake reflects dementia severity. ( English, R; Growdon, JH; Holman, BL; Johnson, KA; Mueller, SP; Nagel, JS; Rosen, TJ, 1988)
"One patient with early Alzheimer's disease was classified as normal by two of the four observers."1.27Diagnosis of Alzheimer's disease and multiple infarct dementia by tomographic imaging of iodine-123 IMP. ( Chang, CC; Cohen, MB; Fitten, J; Graham, LS; Kulkarni, MK; Lake, R; Metter, EJ; Sevrin, R; Woodruff, N; Yamada, L, 1986)
"In those patients diagnosed as having senile dementia of the Alzheimer type a bilateral reduction in IMP uptake in the temporo-parieto-occipital region was always seen."1.27Application of iodine-123-labeled isopropylamphetamine imaging to the study of dementia. ( Besson, J; Cherryman, G; Crawford, J; Gemmell, H; Sharp, P; Smith, F, 1986)

Research

Studies (52)

TimeframeStudies, this research(%)All Research%
pre-199017 (32.69)18.7374
1990's19 (36.54)18.2507
2000's11 (21.15)29.6817
2010's4 (7.69)24.3611
2020's1 (1.92)2.80

Authors

AuthorsStudies
Saigoh, K1
Hirano, M1
Mitsui, Y1
Oda, I1
Ikegawa, A1
Samukawa, M1
Yoshikawa, K2
Yamagishi, Y1
Kusunoki, S1
Nagai, Y1
Nakamagoe, K1
Fujimiya, S1
Koganezawa, T1
Kadono, K1
Shimizu, K1
Fujizuka, N1
Takiguchi, S1
Ueno, T1
Monzen, T1
Tamaoka, A1
Chiba, Y1
Iseki, E1
Fujishiro, H1
Ota, K1
Kasanuki, K1
Suzuki, M1
Hirayasu, Y1
Arai, H9
Sato, K2
Nakagawa, T1
Itoh, M2
Ohta, K1
Hayashi, Y1
Hayakawa, M1
Yamada, Y1
Akanabe, H1
Chikaishi, T1
Nakagawa, K1
Itoh, Y1
Muro, T1
Yanagida, D1
Nakabayashi, R1
Mori, T2
Saito, K1
Ohzawa, K1
Suzuki, C1
Li, S1
Ueda, M1
Wang, MX1
Nishida, E1
Islam, S1
Kobori, M1
Inuzuka, T1
Ishii, K2
Kanda, T1
Uemura, T1
Miyamoto, N1
Yoshikawa, T1
Shimada, K1
Ohkawa, S1
Minoshima, S1
Hanyu, H7
Kume, K1
Sato, T1
Hirao, K2
Kanetaka, H2
Sakurai, H1
Iwamoto, T4
Ushijima, Y2
Okuyama, C2
Mori, S1
Nakamura, T1
Kubota, T2
Nishimura, T2
Sakai, T1
Kuzuhara, S1
Mizumura, S1
Kumita, S1
Cho, K1
Ishihara, M1
Nakajo, H1
Toba, M1
Kumazaki, T1
Ota, T1
Shinotoh, H1
Fukushi, K2
Nagatsuka, S2
Namba, H2
Iyo, M2
Aotsuka, A1
Tanaka, N1
Shiraishi, T1
Tanada, S2
Irie, T2
Kasama, S1
Tachibana, H2
Kawabata, K2
Yoshikawa, H1
Yamada, K1
Kizu, O1
Mito, Y1
Yoshida, K1
Yabe, I1
Makino, K1
Hirotani, M1
Tashiro, K1
Kikuchi, S1
Sasaki, H3
Shimizu, S1
Chikamori, T1
Usui, Y1
Yamashina, A1
Koizumi, K1
Abe, K3
Gemmell, HG2
Sharp, PF3
Evans, NT1
Besson, JA3
Lyall, D1
Smith, FW3
Ishino, Y1
Nakata, H1
Sugita, M1
Fukuchi, M1
Abe, S4
Takasaki, M4
Tamagami, H1
Ikota, N1
Mori, E1
Kitagaki, H1
Sakamoto, S1
Yamaji, S1
Imamura, T1
Ikejiri, Y1
Kono, M1
Kitamura, S2
Koshi, Y2
Komiyama, T2
Sakayori, O2
Komaba, Y2
Ohyama, M2
Mishina, M2
Tsuganesawa, T2
Terashi, A2
Ishiwata, A1
Soya, H1
Nakazawa, M1
Kumakura, Y2
Momose, T3
Oku, S2
Ohtake, T3
Nishikawa, J3
Sasaki, Y1
Ohtomo, K1
Okamura, N2
Shinkawa, M1
Matsui, T2
Nakajo, K1
Maruyama, M2
Hu, XS1
Higuchi, M1
Tanji, H1
Seki, T1
Hirai, H1
Chiba, H1
Hitose, K1
Tanaka, K1
Kuroda, A1
Hamamoto, M1
Miyazaki, T1
Uchiyama, M1
Nagashi, M1
Asano, T2
Suzuki, T4
Katsunuma, H2
Cohen, MB2
Fitten, LJ1
Lake, RR1
Perryman, KM1
Graham, LS2
Sevrin, R2
Amino, S2
Rae-Grant, AD1
Barbour, PJ1
Sirotta, P1
Gross, P1
Kuwabara, Y2
Ichiya, Y2
Otsuka, M2
Tahara, T2
Fukumura, T2
Gunasekera, R2
Ichimiya, A1
Masuda, K2
Kobayashi, Y1
Hatano, N1
Johnson, KA3
Holman, BL4
Rosen, TJ2
Nagel, JS2
English, RJ2
Growdon, JH2
O'Connell, RA1
Van Heertum, RL1
Billick, SB1
Holt, AR1
Gonzalez, A1
Notardonato, H1
Luck, D1
King, LN1
Mitsuyama, Y1
Killen, AR1
Oster, G1
Colditz, GA1
Nishizawa, S1
Yonekura, Y1
Fujita, T1
Mukai, T1
Saji, H1
Fukuyama, H1
Miyoshi, T1
Harada, K1
Ishikawa, M1
Hellman, RS1
Tikofsky, RS1
Collier, BD1
Hoffmann, RG1
Palmer, DW1
Glatt, SL1
Antuono, PG1
Isitman, AT1
Papke, RA1
Jagust, WJ2
Reed, BR2
Seab, JP1
Kramer, JH1
Budinger, TF2
Kosaka, N1
Watanabe, T1
Iio, M1
Derouesne, C1
Rancurel, G1
Le Poncin Lafitte, M1
Rapin, JR1
Lassen, MA1
Mueller, SP1
English, R1
Ebmeier, KP2
Lake, R1
Metter, EJ1
Fitten, J1
Kulkarni, MK1
Yamada, L1
Chang, CC1
Woodruff, N1
Mueller, ST1
Walshe, TM1
Crawford, JR1
Palin, AN1
Gemmel, HG1
Cherryman, GR1
Sharp, P1
Gemmell, H1
Cherryman, G1
Besson, J1
Crawford, J1
Smith, F1
Gibson, RE1
Hill, TC1
Eckelman, WC1
Albert, M1
Reba, RC1

Trials

8 trials available for iofetamine and Alzheimer Disease

ArticleYear
Relationship between cognitive function and regional cerebral blood flow in Alzheimer's disease.
    Nuclear medicine communications, 2002, Volume: 23, Issue:8

    Topics: Aged; Alzheimer Disease; Brain; Cerebrovascular Circulation; Cognition; Cognition Disorders; Female;

2002
Development of quantitative analysis method for stereotactic brain image: assessment of reduced accumulation in extent and severity using anatomical segmentation.
    Annals of nuclear medicine, 2003, Volume: 17, Issue:4

    Topics: Aged; Alzheimer Disease; Anatomy, Cross-Sectional; Brain; Brain Mapping; Female; Humans; Image Inter

2003
A simple method for the detection of abnormal brain regions in Alzheimer's disease patients using [11C]MP4A: comparison with [123I]IMP SPECT.
    Annals of nuclear medicine, 2004, Volume: 18, Issue:3

    Topics: Acetates; Acetylcholinesterase; Aged; Aged, 80 and over; Aging; Alzheimer Disease; Carbon Radioisoto

2004
Cerebral blood flow in Parkinson's disease, dementia with Lewy bodies, and Alzheimer's disease according to three-dimensional stereotactic surface projection imaging.
    Dementia and geriatric cognitive disorders, 2005, Volume: 19, Issue:5-6

    Topics: Aged; Alzheimer Disease; Brain Diseases; Cerebrovascular Circulation; Cognition Disorders; Humans; I

2005
Diagnosis of Alzheimer's disease using brain perfusion SPECT and MR imaging: which modality achieves better diagnostic accuracy?
    European journal of nuclear medicine and molecular imaging, 2005, Volume: 32, Issue:4

    Topics: Aged; Alzheimer Disease; Brain; Brain Mapping; Cerebrovascular Circulation; Female; Humans; Imaging,

2005
[Cerebral hemodynamics in patients with dementia].
    Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics, 1996, Volume: 33, Issue:2

    Topics: Aged; Alzheimer Disease; Amphetamines; Brain; Cerebrovascular Circulation; Dementia, Vascular; Femal

1996
[Stepwise analysis of cerebral blood flow SPECT imaging on standard brain atlas in patients with dementia of Alzheimer's type].
    Kaku igaku. The Japanese journal of nuclear medicine, 1998, Volume: 35, Issue:9

    Topics: Aged; Alzheimer Disease; Brain; Brain Mapping; Cerebrovascular Circulation; Data Interpretation, Sta

1998
SPECT brain imaging in Alzheimer's disease during treatment with oral tetrahydroaminoacridine and lecithin.
    Clinical nuclear medicine, 1992, Volume: 17, Issue:4

    Topics: Administration, Oral; Aged; Aged, 80 and over; Alzheimer Disease; Amphetamines; Brain; Cerebrovascul

1992

Other Studies

44 other studies available for iofetamine and Alzheimer Disease

ArticleYear
Memantine administration prevented chorea movement in Huntington's disease: a case report.
    Journal of medical case reports, 2023, Oct-16, Volume: 17, Issue:1

    Topics: Aged; Alzheimer Disease; Chorea; Dyskinesias; Female; Humans; Huntington Disease; Iofetamine; Male;

2023
Vestibular Function Impairment in Alzheimer's Disease.
    Journal of Alzheimer's disease : JAD, 2015, Volume: 47, Issue:1

    Topics: Acoustic Stimulation; Age Factors; Aged; Aged, 80 and over; Alzheimer Disease; Antipsychotic Agents;

2015
Early differential diagnosis between Alzheimer's disease and dementia with Lewy bodies: Comparison between (18)F-FDG PET and (123)I-IMP SPECT.
    Psychiatry research. Neuroimaging, 2016, Mar-30, Volume: 249

    Topics: Aged; Alzheimer Disease; Cognitive Dysfunction; Diagnosis, Differential; Early Diagnosis; Female; Fl

2016
Improvement of memory recall by quercetin in rodent contextual fear conditioning and human early-stage Alzheimer's disease patients.
    Neuroreport, 2016, 06-15, Volume: 27, Issue:9

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aniline Compounds; Animals; Antioxidants; Benzothiazoles

2016
Computer-assisted diagnostic system for neurodegenerative dementia using brain SPECT and 3D-SSP.
    European journal of nuclear medicine and molecular imaging, 2009, Volume: 36, Issue:5

    Topics: Aged; Alzheimer Disease; Automation; Cerebrovascular Circulation; Dementia; Diagnosis, Computer-Assi

2009
Regional differences in cortical benzodiazepine receptors of Alzheimer, vascular, and mixed dementia patients.
    Journal of the neurological sciences, 2012, Dec-15, Volume: 323, Issue:1-2

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Brain Mapping; Cerebral Cortex; Cerebrovascu

2012
[Regional cerebral blood flow measured by three-dimensional stereotactic surface projections (3D-SSP) of 123I-IMP SPECT in Parkinson disease patients with cognitive impairment].
    Rinsho shinkeigaku = Clinical neurology, 2003, Volume: 43, Issue:4

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Cerebrovascular Circulation; Cognition Disorders; Female

2003
Brain 3D-SSP SPECT analysis in dementia with Lewy bodies, Parkinson's disease with and without dementia, and Alzheimer's disease.
    Clinical neurology and neurosurgery, 2005, Volume: 107, Issue:5

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Case-Control Studies; Cerebrovascular Circulation; Femal

2005
Comparative value of brain perfusion SPECT and [(123)I]MIBG myocardial scintigraphy in distinguishing between dementia with Lewy bodies and Alzheimer's disease.
    European journal of nuclear medicine and molecular imaging, 2006, Volume: 33, Issue:3

    Topics: 3-Iodobenzylguanidine; Aged; Alzheimer Disease; Brain; Diagnosis, Differential; Humans; Iofetamine;

2006
Single photon emission tomography with 123I-isopropylamphetamine in Alzheimer's disease and multi-infarct dementia.
    Lancet (London, England), 1984, Dec-08, Volume: 2, Issue:8415

    Topics: Aged; Alzheimer Disease; Amphetamines; Cerebral Infarction; Cerebral Ventricles; Dementia; Diagnosis

1984
[A case of Down's syndrome with progressive dementia of Alzheimer type].
    Kaku igaku. The Japanese journal of nuclear medicine, 1993, Volume: 30, Issue:2

    Topics: Adult; Alzheimer Disease; Amphetamines; Brain; Cerebrovascular Circulation; Down Syndrome; Humans; I

1993
A comparative I-123 IMP SPECT study in Binswanger's disease and Alzheimer's disease.
    Clinical nuclear medicine, 1993, Volume: 18, Issue:4

    Topics: Aged; Alzheimer Disease; Amphetamines; Brain; Cerebrovascular Circulation; Dementia, Vascular; Demye

1993
Brain acetylcholinesterase activity: validation of a PET tracer in a rat model of Alzheimer's disease.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1996, Volume: 37, Issue:4

    Topics: Acetates; Acetylcholinesterase; Alzheimer Disease; Amphetamines; Animals; Brain; Carbon Radioisotope

1996
The clinical utility of visual evaluation of scintigraphic perfusion patterns for Alzheimer's disease using I-123 IMP SPECT.
    Clinical nuclear medicine, 1996, Volume: 21, Issue:2

    Topics: Aged; Alzheimer Disease; Amphetamines; Brain; Cognition Disorders; Dementia; Diagnosis, Differential

1996
[Benzodiazepine receptor and cerebral blood flow in early Alzheimer's disease--SPECT study using 123I-iomazenil and 123I-IMP].
    Kaku igaku. The Japanese journal of nuclear medicine, 1996, Volume: 33, Issue:1

    Topics: Aged; Alzheimer Disease; Amphetamines; Brain; Cerebrovascular Circulation; Female; Flumazenil; Human

1996
[A quantitative study of regional cerebral blood flow in patients with dementia of Alzheimer type using single photon emission computed tomography--clinical application of the IMP autoradiographic method (IMP ARG method)].
    Kaku igaku. The Japanese journal of nuclear medicine, 1996, Volume: 33, Issue:9

    Topics: Aged; Alzheimer Disease; Amphetamines; Autoradiography; Brain; Cerebrovascular Circulation; Female;

1996
[Analysis of cerebral blood flow SPECT imaging on standard brain atlas in patients with dementia of Alzheimer type].
    Kaku igaku. The Japanese journal of nuclear medicine, 1998, Volume: 35, Issue:1

    Topics: Aged; Alzheimer Disease; Amphetamines; Cerebrovascular Circulation; Female; Humans; Iodine Radioisot

1998
[Prediction of progression in patients with mild cognitive impairment using IMP-SPECT].
    Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics, 2000, Volume: 37, Issue:12

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Brain; Cerebrovascular Circulation; Cognition Disorders;

2000
Combined Analysis of CSF Tau Levels and [(123)I]Iodoamphetamine SPECT in Mild Cognitive Impairment: Implications for a Novel Predictor of Alzheimer's Disease.
    The American journal of psychiatry, 2002, Volume: 159, Issue:3

    Topics: Aged; Alzheimer Disease; Cognition Disorders; Diagnosis, Differential; Female; Gyrus Cinguli; Humans

2002
[Diagnostic imaging of dementia by SPECT].
    Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica, 1992, Volume: 94, Issue:10

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amphetamines; Brain; Cerebrovascular Circulation; Estrog

1992
[Cerebral hemodynamic difference between early- and late-onset Alzheimer's disease by circumferential profile analysis with 123I-IMP brain SPECT].
    Kaku igaku. The Japanese journal of nuclear medicine, 1992, Volume: 29, Issue:10

    Topics: Aged; Alzheimer Disease; Amphetamines; Cerebrovascular Circulation; Female; Hemodynamics; Humans; Io

1992
[Diagnostic accuracy of single photon emission CT in Alzheimer-type dementia].
    Nihon Ronen Igakkai zasshi. Japanese journal of geriatrics, 1992, Volume: 29, Issue:6

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amphetamines; Cerebrovascular Circulation; Female; Human

1992
[123I-IMP SPECT study on patients with amnestic syndrome].
    Kaku igaku. The Japanese journal of nuclear medicine, 1992, Volume: 29, Issue:6

    Topics: Aged; Alzheimer Disease; Amnesia; Amphetamines; Cerebrovascular Circulation; Female; Humans; Iodine

1992
Alzheimer's disease in Down's syndrome with SPECT.
    Clinical nuclear medicine, 1991, Volume: 16, Issue:7

    Topics: Alzheimer Disease; Amphetamines; Brain; Down Syndrome; Humans; Iodine Radioisotopes; Iofetamine; Mal

1991
Comparison of I-123 IMP and Tc-99m HMPAO SPECT studies with PET in dementia.
    Annals of nuclear medicine, 1990, Volume: 4, Issue:3

    Topics: Aged; Alzheimer Disease; Amphetamines; Dementia; Dementia, Multi-Infarct; Female; Humans; Iodine Rad

1990
Differential diagnosis of bilateral parietal abnormalities in I-123 IMP SPECT imaging.
    Clinical nuclear medicine, 1990, Volume: 15, Issue:12

    Topics: Aged; Alzheimer Disease; Amphetamines; Brain Diseases; Dementia, Multi-Infarct; Diagnosis, Different

1990
[Asymmetry of cerebral blood flow in patients with senile dementia of Alzheimer type by SPECT using I-123 IMP].
    Kaku igaku. The Japanese journal of nuclear medicine, 1990, Volume: 27, Issue:12

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amphetamines; Cerebrovascular Circulation; Female; Human

1990
Iofetamine I 123 single photon emission computed tomography is accurate in the diagnosis of Alzheimer's disease.
    Archives of internal medicine, 1990, Volume: 150, Issue:4

    Topics: Aged; Alzheimer Disease; Amphetamines; Brain; Female; Humans; Iodine Radioisotopes; Iofetamine; Male

1990
Single photon emission computed tomography (SPECT) with [123I]IMP in the differential diagnosis of psychiatric disorders.
    The Journal of neuropsychiatry and clinical neurosciences, 1989,Spring, Volume: 1, Issue:2

    Topics: Adult; AIDS Dementia Complex; Alzheimer Disease; Amphetamines; Bipolar Disorder; Brain; Brain Mappin

1989
[123I-IMP-SPECT finding of a case of presenile dementia with motor neuron disease--comparison between Alzheimer's disease, Pick's disease and presenile dementia with motor neuron disease].
    Seishin shinkeigaku zasshi = Psychiatria et neurologia Japonica, 1989, Volume: 91, Issue:7

    Topics: Alzheimer Disease; Amphetamines; Brain; Dementia; Female; Humans; Iodine Radioisotopes; Iofetamine;

1989
An assessment of the role of 123I-N-isopropyl-p-iodoamphetamine with single-photon emission computed tomography in the diagnosis of stroke and Alzheimer's disease.
    Nuclear medicine communications, 1989, Volume: 10, Issue:4

    Topics: Alzheimer Disease; Amphetamines; Cerebrovascular Disorders; Humans; Iodine Radioisotopes; Iofetamine

1989
Regional dynamics of N-isopropyl-(123I)p-iodoamphetamine in human brain.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1989, Volume: 30, Issue:2

    Topics: Alzheimer Disease; Amphetamines; Brain; Brain Neoplasms; Cerebrovascular Circulation; Cerebrovascula

1989
Alzheimer disease: quantitative analysis of I-123-iodoamphetamine SPECT brain imaging.
    Radiology, 1989, Volume: 172, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Amphetamines; Brain; Female; Humans; Iodine Radio

1989
Clinical-physiologic correlates of Alzheimer's disease and frontal lobe dementia.
    American journal of physiologic imaging, 1989, Volume: 4, Issue:3

    Topics: Aged; Alzheimer Disease; Amphetamines; Brain; Cerebrovascular Circulation; Dementia; Female; Frontal

1989
[N-isopropyl I-123 p-iodoamphetamine (IMP) brain SPECT in Alzheimer's disease].
    Kaku igaku. The Japanese journal of nuclear medicine, 1989, Volume: 26, Issue:9

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amphetamines; Brain; Dementia; Female; Humans; Iodine Ra

1989
Variability of cerebral blood flow defects in Alzheimer's disease on 123iodo-isopropyl-amphetamine and single photon emission tomography.
    Lancet (London, England), 1985, Jun-01, Volume: 1, Issue:8440

    Topics: Alzheimer Disease; Amphetamines; Cerebrovascular Circulation; Dementia; Diagnosis, Differential; Hum

1985
Single photon emission computed tomography in Alzheimer's disease. Abnormal iofetamine I 123 uptake reflects dementia severity.
    Archives of neurology, 1988, Volume: 45, Issue:4

    Topics: Aged; Alzheimer Disease; Amphetamines; Brain; Cerebrovascular Circulation; Female; Humans; Iodine Ra

1988
A comparison of Tc-99m HM-PAO and I-123 IMP cerebral SPECT images in Alzheimer's disease and multi-infarct dementia.
    European journal of nuclear medicine, 1988, Volume: 14, Issue:9-10

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amphetamines; Brain; Dementia, Multi-Infarct; Humans; Io

1988
Diagnosis of Alzheimer's disease and multiple infarct dementia by tomographic imaging of iodine-123 IMP.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1986, Volume: 27, Issue:6

    Topics: Alzheimer Disease; Amphetamines; Brain; Cerebral Infarction; Dementia; Diagnosis, Differential; Eval

1986
Cerebral perfusion imaging in Alzheimer's disease. Use of single photon emission computed tomography and iofetamine hydrochloride I 123.
    Archives of neurology, 1987, Volume: 44, Issue:2

    Topics: Aged; Aged, 80 and over; Alzheimer Disease; Amphetamines; Brain; Cerebrovascular Circulation; Female

1987
The diagnosis of dementia with single photon emission computed tomography.
    Archives of neurology, 1987, Volume: 44, Issue:3

    Topics: Aged; Alzheimer Disease; Amphetamines; Brain; Cerebrovascular Circulation; Dementia; Female; Humans;

1987
Nuclear magnetic resonance imaging and single photon emission tomography with radio-iodine labelled compounds in the diagnosis of dementia.
    Acta psychiatrica Scandinavica, 1987, Volume: 75, Issue:5

    Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Amphetamines; Brain; Cerebral Infarction; Dementi

1987
Application of iodine-123-labeled isopropylamphetamine imaging to the study of dementia.
    Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 1986, Volume: 27, Issue:6

    Topics: Aged; Alcoholism; Alzheimer Disease; Amphetamines; Brain; Cerebral Infarction; Cerebrovascular Circu

1986
Muscarinic acetylcholine receptors in Alzheimer's disease. In vivo imaging with iodine 123-labeled 3-quinuclidinyl-4-iodobenzilate and emission tomography.
    JAMA, 1985, Dec-06, Volume: 254, Issue:21

    Topics: Alzheimer Disease; Amphetamines; Brain; Cerebrovascular Circulation; Humans; Iodine Radioisotopes; I

1985